Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin

Scandinavian Journal of Infectious Diseases

Volumn 37, Issue 2, 2005, Pages 142-145

  Michalopoulos, Argyris ^a   Kasiakou, Sofia K ^b   Rosmarakis, Evangelos S ^b   Falagas, Matthew E ^b,c,d  

^a Department of Intensive Care Unit ^*  (Greece)

^b HENRY DUNANT HOSPITAL   (Greece)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Alfa HealthCare   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTIHISTAMINIC AGENT; CARBAPENEM; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; COLISTIN; CORTICOSTEROID; DEXAMETHASONE; GENTAMICIN; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MANNITOL; PHENYTOIN; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; SULTAMICILLIN; TIMENTIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANAMNESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; ARTIFICIAL VENTILATION; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATION; BRADYCARDIA; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HEMORRHAGE; BRAIN VENTRICLE PERITONEUM SHUNT; BRONCHUS SECRETION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; CONTINUOUS INFUSION; CROSS REACTION; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DYSPNEA; FOLLOW UP; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEADACHE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYDROCEPHALUS; HYPERTENSION; INTENSIVE CARE UNIT; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; MYDRIASIS; NEUROLOGIC EXAMINATION; NEUROSURGERY; PROTON RADIATION; PSEUDOMONAS AERUGINOSA; RADIOSURGERY; SALVAGE THERAPY; STAPHYLOCOCCUS AUREUS; STUPOR; TREATMENT OUTCOME; VOMITING;

EID: 14544291966     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540410020776-1     Document Type: Article

References (13)

1. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 1998;26:1-10.
2. Craig WA, Ebert SC. Continuous infusion of beta-lactam antibiotics. Antimicrob Agents Chemother 1992;36:2577-83.
3. Li J, Turnidge J, Milne R, Nation RL, Coulthard K. In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 2001;45:781-5.
4. Nicolau DP, McNabb J, Lacy MK, Quintiliani R, Nightingale CH. Continuous versus intermittent administration of ceftazidime in intensive care unit patients with nosocomial pneumonia. Int J Antimicrob Agents 2002;17:497-504.
5. McNabb JJ, Nightingale CH, Quintiliani R, Nicolau DP. Cost-effectiveness of ceftazidime by continuous infusion versus intermittent infusion for nosocomial pneumonia. Pharmacotherapy 2001;21:549-55.
6. Klepser ME, Patel KB, Nicolau DP, Quintiliani R, Nightingale CH. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis. Pharmacotherapy 1998;18:1069-74.
7. Georges B, Archambaud M, Saivin S, Decun JF, Cougot P, Mazerolles M, et al. Continuous versus intermittent cefepime infusion in critical care. Preliminary results Pathol Biol (Paris) 1999;47:483-5.
8. Ryan G, Mukhopadhyay S, Singh M. Nebulized antipseudomonal antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2003; CD001021.
9. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez FJ, Barrero-Almodovar AE, Garcia-Garmendia JL, Bernabeu-Wittel IM, et al. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 2003;36:1111-8.
10. Linden PK, Kusne S, Coley K, Fontes P, Kramer DJ, Paterson D. Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aeruginosa. Clin Infect Dis 2003;37:e154-60.
11. Stein A, Raoult D. Colistin: an antimicrobial for the 21st century? Clin Infect Dis 2002;35:901-2.
12. Jimenez-Mejias ME, Pichardo-Guerrero C, Marquez-Rivas FJ, Martin-Lozano D, Prados T, Pachon J. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur J Clin Microbiol Infect Dis 2002;21:212-4.
13. Reed MD, Stern RC, O'Riordan MA, Blumer JL. The pharmacokinetics of colistin in patients with cystic fibrosis. J Clin Pharmacol 2001;41:645-54.